Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

MW Mandernach, RJ Beyth… - Therapeutics and clinical …, 2015 - Taylor & Francis
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …
被引用次数：47 相关文章
[HTML] nih.gov

[HTML][HTML] Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

MW Mandernach, RJ Beyth… - Therapeutics and Clinical …, 2015 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …
[PDF] researchgate.net

[PDF][PDF] Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

M w Mandernach - Therapeutics and Clinical Risk Management, 2015 - researchgate.net
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

MW Mandernach, RJ Beyth… - Therapeutics and Clinical …, 2015 - go.gale.com
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

MW Mandernach, RJ Beyth… - … and clinical risk …, 2015 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

MW Mandernach, RJ Beyth… - Therapeutics and Clinical …, 2015 - dovepress.com
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …
[PDF] semanticscholar.org

[PDF][PDF] Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

M w Mandernach - Therapeutics and Clinical Risk …, 2015 - pdfs.semanticscholar.org
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

MW Mandernach, RJ Beyth… - … and Clinical Risk …, 2015 - search.proquest.com
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …
[PDF] scienceopen.com

[PDF][PDF] Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review

M w Mandernach - Therapeutics and Clinical Risk Management, 2015 - scienceopen.com
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …

Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review.

MW Mandernach, RJ Beyth… - Therapeutics and Clinical …, 2015 - europepmc.org
Venous thromboembolism (VTE) results in significant morbidity and mortality. The
prevention and treatment of VTE is managed with anticoagulant therapy, historically …